Abstract #0118

To assess and follow-up the mpMRI and prostate volumetric changes after whole prostate MR-guided transurethral prostate ultrasound ablation.

Afshin Azadikhah¹, Holden Wu², Melina Hosseiny², and Steven S Raman²

¹Radiology, University of California, Los Angeles, Los Angeles, CA, United States, ²University of California, Los Angeles, Los Angeles, CA, United States

To evaluate the changes of 3 Tesla (3T) mpMRI and PSA parameters before and during multiple time points after whole gland prostate cancer (PCa) treatment using MRI-guided directional transurethral ultrasound ablation (TULSA). Patients were treated and followed-up for 1, 3, 6 and 12-month in retrospective, cohort, a trial study from October 2017 to February 2019. The mean ADC value, T2W, NPV, PSAD, and prostate volume were significantly decreased after 1 to 12-month follow-up with significant differences. MRI-guided TULSA uses a minimally-invasive transurethral approach, and this appears to be an effective method especially in patients with localized, organ-confined prostate cancer.

How to access this content:

For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.

After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.

After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.

Click here for more information on becoming a member.